Drug Prevention of Reperfusion Lesions during Thrombolytic Therapy for Myocardial Infarction

Objective: to evaluate the efficacy of mexicor used to protect cardiac metabolism in patients with myocardial infarction during thrombolytic therapy with streptokinase. Subjects and methods. Fifty-four patients (mean age 51.2±5.5 years) with myocardial infarction, who underwent thrombolytic therapy...

Full description

Bibliographic Details
Main Authors: G. A. Boyarinov, A. A. Usanova, I. S. Kotlov, A. S. Saushev, A. P. Komkov
Format: Article
Language:English
Published: Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia 2010-02-01
Series:Общая реаниматология
Online Access:https://www.reanimatology.com/rmt/article/view/508